Cargando…
Skp2 and Skp2B team up against Rb and p53
The Skp2 locus encodes two proteins, Skp2 and Skp2B. The role of Skp2 in the ubiquitin-dependent degradation of key regulators of the retinoblastoma protein pathway has been well established. More recent work from the McCormick's group suggested that Skp2 has an ubiquitin-independent function i...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035582/ https://www.ncbi.nlm.nih.gov/pubmed/21255415 http://dx.doi.org/10.1186/1747-1028-6-1 |
_version_ | 1782197788763750400 |
---|---|
author | Germain, Doris |
author_facet | Germain, Doris |
author_sort | Germain, Doris |
collection | PubMed |
description | The Skp2 locus encodes two proteins, Skp2 and Skp2B. The role of Skp2 in the ubiquitin-dependent degradation of key regulators of the retinoblastoma protein pathway has been well established. More recent work from the McCormick's group suggested that Skp2 has an ubiquitin-independent function in the regulation of the p53 pathway. Adding to this observation, we reported that Skp2B also regulates the activity of p53 by degrading a distinct substrate, prohibitin. Since prohibitin has been implicated in the regulation of the Rb pathway, collectively, these observations suggest that Skp2 and Skp2B team up against p53 and Rb. |
format | Text |
id | pubmed-3035582 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-30355822011-02-09 Skp2 and Skp2B team up against Rb and p53 Germain, Doris Cell Div Commentary The Skp2 locus encodes two proteins, Skp2 and Skp2B. The role of Skp2 in the ubiquitin-dependent degradation of key regulators of the retinoblastoma protein pathway has been well established. More recent work from the McCormick's group suggested that Skp2 has an ubiquitin-independent function in the regulation of the p53 pathway. Adding to this observation, we reported that Skp2B also regulates the activity of p53 by degrading a distinct substrate, prohibitin. Since prohibitin has been implicated in the regulation of the Rb pathway, collectively, these observations suggest that Skp2 and Skp2B team up against p53 and Rb. BioMed Central 2011-01-21 /pmc/articles/PMC3035582/ /pubmed/21255415 http://dx.doi.org/10.1186/1747-1028-6-1 Text en Copyright ©2011 Germain; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Commentary Germain, Doris Skp2 and Skp2B team up against Rb and p53 |
title | Skp2 and Skp2B team up against Rb and p53 |
title_full | Skp2 and Skp2B team up against Rb and p53 |
title_fullStr | Skp2 and Skp2B team up against Rb and p53 |
title_full_unstemmed | Skp2 and Skp2B team up against Rb and p53 |
title_short | Skp2 and Skp2B team up against Rb and p53 |
title_sort | skp2 and skp2b team up against rb and p53 |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035582/ https://www.ncbi.nlm.nih.gov/pubmed/21255415 http://dx.doi.org/10.1186/1747-1028-6-1 |
work_keys_str_mv | AT germaindoris skp2andskp2bteamupagainstrbandp53 |